Claim-by-claim review
Every claim checked against your PI, CSRs, studies, and past campaigns, with the source cited on every flag.
MLR review.
Assessed in seconds.
- Every claim checked against your PI, CSRs, and past campaigns
- FDA letters and enforcement actions indexed in real time
- Findings cited and routed to Medical, Legal, and Regulatory
The problem
One missed claim can mean a public FDA letter, a pulled campaign, and months of remediation. Arca catches it before it ships.
FDA enforcement checks
Language the FDA has already flagged at another company gets caught in your review, not in market.
Your SOP, run by an agent
Your review process, followed step by step on every asset, with findings routed to Medical, Legal, or Regulatory.
The benefits of Arca.
Risk caught in review, not in market.
To check every claim in an asset, with the source cited on each flag.
From FDA publication to a new letter being searchable in your review.
Regulatory sources indexed, from FDA letters to DailyMed and PubMed.
SOC 2 Type II. Single tenant. Full audit trail. Your data is never used to train models.
